| Centuria Industrial REIT (CIP) ORDINARY UNITS FULLY PAID |
Real Estate |
$1,879 |
Appendix 3Y - Roger Dobson
|
27 Feb 2026 3:21PM |
$3.210 |
$3.010 |
fallen by
6.23%
|
|
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$7 |
Preliminary Final Report
|
27 Feb 2026 3:21PM |
$0.006 |
$0.006 |
fallen by
0%
|
|
WHK - Price-sensitive ASX Announcement
Full Release
Key Points
- Recognized US$2.1M revenue in 2025.
- Net loss after tax of US$1.2M.
- Signed a Teaming Agreement with LEIDOS for the APOLLO contract.
- Launched RiskWise joint solution with Novera.
- Achieved key contracts in cybersecurity and defense sectors.
- Expanded client base focusing on AUKUS, CMMC, and AU Essential 8 Compliance.
- Revenue included US$801K unearned revenue from 2024.
- Net asset position improved to US$450K.
- Cash flow challenges with a US$1.57M net operating cash outflow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$73 |
Appendix 4D and Half Year Report
|
27 Feb 2026 3:20PM |
$0.059 |
$0.027 |
fallen by
54.24%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Botanix Pharmaceuticals Ltd increased sales revenue to $16.5 million in H1 FY26.
- Net loss after tax for the period was $33.2 million.
- Sofdra prescriptions grew by 171% due to expanded sales efforts.
- The company aims to reduce its cost of goods sold by securing alternative API suppliers.
- Botanix plans to expand Sofdra licensing to other regions to increase revenue.
- A capital raising of approximately $45 million was announced.
- The financial position as of 31 December 2025 showed net assets of $54 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$74 |
Appendix 4G Corporate Governance Statement
|
27 Feb 2026 3:18PM |
$1.490 |
$1.385 |
fallen by
7.05%
|
|
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,374 |
Application for quotation of securities - 4DX
|
27 Feb 2026 3:18PM |
$3.790 |
$4.020 |
risen by
6.07%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$74 |
Full Year Statutory Accounts
|
27 Feb 2026 3:17PM |
$1.490 |
$1.385 |
fallen by
7.05%
|
|
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$36 |
Notification of cessation of securities - TEK
|
27 Feb 2026 3:13PM |
$0.125 |
$0.098 |
fallen by
21.60%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$86 |
Notification of cessation of securities - TOP
|
27 Feb 2026 3:10PM |
$0.640 |
$0.510 |
fallen by
20.31%
|
|
| Westpac Banking Corporation (WBC) ORDINARY FULLY PAID |
Financials |
$131,511 |
Notification regarding unquoted securities - WBC
|
27 Feb 2026 3:07PM |
$42.610 |
$38.450 |
fallen by
9.76%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$65 |
Completion of Acquisition of Infrawork Holdings
|
27 Feb 2026 3:04PM |
$0.665 |
$0.590 |
fallen by
11.28%
|
|
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$9 |
Proposed Application for Quotation of Unlisted Options
|
27 Feb 2026 3:01PM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$12 |
FY26 H1 Financial Results and Operational Highlights
|
27 Feb 2026 2:58PM |
$0.024 |
$0.023 |
fallen by
4.17%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- 20% increase in group revenue to $10.2 million.
- Net operating cash inflow of $0.5 million, first since FY19.
- Cost savings of $1.3 million achieved.
- Powerhouse revenue increased 22% to $1.2 million.
- Engineering revenue rose 20%, with 144% increase in EBITDA.
- 100% compliance with financial covenants maintained.
- Powerhouse operational reliability over 99.9%.
- Strong tender pipeline in Powerhouse and Engineering sectors.
- Strategic geographic expansion in Australia.
- Focus on scalable deployment and long-term partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 2:57PM |
$0.028 |
$0.017 |
fallen by
38.18%
|
|
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$17 |
Appendix 4E and Preliminary Final Report
|
27 Feb 2026 2:57PM |
$0.008 |
$0.010 |
risen by
25%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Decrease in revenue by 15.63% to AUD 810,000.
- Net loss increased by 21.51% to AUD 339,000.
- No dividend declared for the financial year.
- Compliance with Australian Accounting Standards.
- Emphasis of Matter related to going concern in audit.
- Net liabilities of AUD 1,001,000 as of year-end.
- Cash and cash equivalents at AUD 546,000 at year-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OpenLearning Limited (OLL) ORDINARY FULLY PAID |
Information Technology |
$16 |
Preliminary Final Report
|
27 Feb 2026 2:56PM |
$0.027 |
$0.020 |
fallen by
25.93%
|
|
OLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 39.4% to $3,182,221.
- Net loss of $4,096,692 for the year 2025.
- Significant SaaS contract growth in Philippines and Malaysia.
- AI tools integrated into the platform, boosting institutional sales.
- Balance sheet strengthened through $2.6 million equity placement.
- Challenges include customer retention and competitive innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$320 |
Change of Director's Interest Notice - Mr Ryan Kolln
|
27 Feb 2026 2:55PM |
$1.855 |
$1.195 |
fallen by
35.58%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$8 |
FY25 Appendix 4E and Annual Report
|
27 Feb 2026 2:55PM |
$0.028 |
$0.017 |
fallen by
38.18%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported an increase in loss after income tax to AUD 4,309,456.
- Total comprehensive income slightly improved due to currency translation gains.
- Total assets decreased and liabilities increased, leading to higher equity deficiency.
- Engaged in significant financing activities through share and convertible note issuance.
- Detailed changes in equity, cash flows, and financial instruments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$44 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:54PM |
$0.060 |
$0.056 |
fallen by
6.67%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax for the half-year was $494,166.
- Total comprehensive income was $502,758.
- Net cash used in operating activities was $750,159.
- Equity increased to $2,172,366.
- No dividends were paid, recommended, or declared.
- A material uncertainty exists regarding going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$12 |
Appendix 4D - Interim Financial Report - FY26 H1
|
27 Feb 2026 2:53PM |
$0.024 |
$0.023 |
fallen by
4.17%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Synertec Corporation Limited reported a total revenue of $10,182,811 for the half-year ended 31 December 2025.
- The company experienced a total comprehensive loss of $2,530,453 during this period.
- The net tangible assets per share decreased from 1.5 cents to 0.5 cents, marking a 68% reduction.
- No dividends were declared or paid during the reporting period.
- The company issued 7.8 million warrants as part of an extension facility, replacing 18.5 million warrants previously issued.
- Revenue from the Engineering segment was $7,651,733, while the Technology segment generated $1,207,875.
- Operating segments are divided into Engineering Solutions and Technology and Future Business.
- The company remained compliant with all financing covenants and continued to operate on a going concern basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raptor Metals Ltd (RAP) ORDINARY FULLY PAID |
Materials |
$18 |
Application for quotation of securities - RAP
|
27 Feb 2026 2:53PM |
$0.056 |
$0.047 |
fallen by
16.07%
|
|
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$23 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:50PM |
$0.035 |
$0.035 |
fallen by
0%
|
|
CQT - Price-sensitive ASX Announcement
Full Release
Key Points
- CONNEQT Health Limited completed a $3.1 million institutional placement and a $2 million Convertible Note Subscription Agreement.
- The company changed its name from Cardiex Limited to CONNEQT Health Limited, reflecting its focus on an integrated vascular health platform.
- Revenue increased by 40% to $2,284,763, with a significant boost from sales of the CONNEQT Pulse device.
- Net loss for the period was $5,992,616, attributed to increased marketing expenses and operational restructuring.
- CONNEQT transitioned to a recurring revenue model, converting clinical pilots into contracted agreements.
- The company implemented a subscription model via the CONNEQT App and reported encouraging early adoption rates.
- CONNEQT Health Limited reported improved operating discipline and reduced costs through centralization of R&D and engineering.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Scheme Booklet registered with ASIC
|
27 Feb 2026 2:49PM |
$4.685 |
$4.790 |
risen by
2.24%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Scheme Booklet related to Insignia Financial Ltd's Scheme of Arrangement.
- Contains financial assessments and valuations by Kroll.
- Details fiscal years ending June 2024 and 2025, and first half of 2026.
- Includes Independent Expert's Report and Scheme Implementation Deed.
- Lodged with ASIC as part of regulatory compliance.
- Targets revenue growth and operational expense management.
- Provides shareholders with information to decide on the scheme.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$73 |
Change of Director's Interest Notice
|
27 Feb 2026 2:47PM |
$0.029 |
$0.033 |
risen by
13.79%
|
|
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$551 |
Daily Estimate NTA for 26.02.2026
|
27 Feb 2026 2:47PM |
$2.010 |
$1.970 |
fallen by
1.99%
|
|
| Loftus Peak Global Disruption Hedged Active ETF (LPHD) |
Financials |
$109 |
Monthly Portfolio Disclosure - January 2026
|
27 Feb 2026 2:47PM |
$9.120 |
$10.130 |
risen by
11.07%
|
|
Call 1300 880 160
Start a chat
Schedule a call
